Changes during perimenopause and menopause can affect sleep, body temperature, vaginal and sexual health, menstrual patterns, and how you feel from one day to the next.
You do not have to decide on your own whether hormones are responsible or whether hormone replacement therapy is right for you.
Brazos Vitality & Precision Wellness provides personalized hormone evaluation in Richwood, Texas for women who want to better understand their symptoms and available options.
When hormone replacement therapy is appropriate, the decision should consider your symptoms, health history, stage of life, potential benefits and risks, personal preferences, and the type of hormone therapy being considered.
Menopause does not look the same for every woman. For some, the transition happens with relatively few symptoms. For others, changes begin years before the final menstrual period and become difficult to ignore.
Hot flashes may interrupt a meeting or appear without warning. Night sweats can make it difficult to get consistent sleep. Periods may become less predictable. Vaginal dryness or discomfort may affect intimacy. Some women notice several changes at once and are unsure whether they are connected. This stage leading up to menopause is known as perimenopause. Hormone production can fluctuate during this transition, and symptoms can change over time. Eventually, menopause is reached after 12 consecutive months without a menstrual period when there is no other cause. These changes are normal parts of reproductive aging, but that does not mean symptoms have to be dismissed when they are interfering with daily life.
Hormone replacement therapy is one option that may be considered for certain women experiencing bothersome menopausal symptoms.
The question is not simply whether HRT “works.” The more useful question is whether a particular type of hormone therapy is appropriate for you.
Hormone replacement therapy, commonly called HRT, involves using hormone medication to replace or supplement hormones that decline during the menopause transition.
You may also see it called menopausal hormone therapy, or MHT. Hormone therapy for menopause most commonly involves estrogen. Depending on the woman and whether she has a uterus, a progestogen may also be needed. The Menopause Society describes hormone therapy as replacing hormones, primarily estrogen and progestogens, that are lost during the menopause transition. But HRT is not one single medication. Hormones can be delivered in different forms and doses, and different approaches may be used depending on the symptoms being addressed and the woman’s individual circumstances. That is why “Should I take HRT?” is usually not the only question. Other questions matter too:
Understanding where you are in the menopause transition can make the HRT conversation easier to understand.
Perimenopause is the transition leading up to menopause. During this time, ovarian hormone production changes and menstrual cycles can become less predictable. Some women begin experiencing hot flashes, night sweats, sleep changes, vaginal symptoms, or other concerns during this stage. Perimenopause can begin before periods stop completely. That is important because a woman does not necessarily have to wait until menopause has occurred before discussing symptoms with a healthcare professional.
Menopause is reached after 12 consecutive months without a menstrual period when there is no other explanation. Hormone-related symptoms do not necessarily stop at that point. Some women continue experiencing hot flashes, night sweats, vaginal dryness, or other symptoms after menopause.
Postmenopause refers to the years following menopause. Health considerations can change during this stage, which is one reason the timing of hormone therapy and the woman's current health matter when deciding whether HRT is appropriate.
Menopausal hormone therapy has established uses, but it should not be presented as a solution for every symptom a woman experiences in midlife.
Its clearest role is in addressing certain symptoms related to menopause.
Hot flashes, also called vasomotor symptoms, are among the most recognizable symptoms of the menopause transition. They can range from occasional warmth to episodes that interfere with work, sleep, or daily activities. Hormone therapy remains the most effective therapy for bothersome menopausal vasomotor symptoms such as hot flashes.
Night sweats are hot flashes that occur during sleep. For some women, repeated episodes can contribute to disrupted sleep and next-day fatigue. When night sweats are related to menopause, hormone therapy may help reduce these vasomotor symptoms.
Declining estrogen can affect vaginal and urinary tissues. Women may experience dryness, irritation, discomfort during sexual activity, or other genitourinary symptoms. Depending on the symptoms, local vaginal estrogen or another appropriate therapy may be considered rather than systemic hormone therapy. The Menopause Society notes that low-dose vaginal estrogen therapy can be effective for genitourinary symptoms of menopause.
Sleep problems can have many causes. When hot flashes and night sweats repeatedly wake a woman, addressing those menopausal symptoms may also improve the disruption they cause. But poor sleep by itself should not automatically be assumed to be a hormone deficiency.
Women sometimes report changes in mood, concentration, sexual health, body composition, or energy during midlife. These concerns deserve to be heard, but they also deserve careful evaluation because they can have multiple causes. HRT should not be presented as a universal solution for every midlife symptom.
You do not need to determine on your own whether HRT is the answer.
Start with a conversation about what you are experiencing, your health history, and which options may be appropriate.
Not necessarily. This is one area where online hormone marketing can create confusion. Women are sometimes led to believe that a large hormone panel is required to “prove” that they are in perimenopause or menopause before symptoms can be addressed.
The reality is more individualized.
During perimenopause, hormone levels can fluctuate. A laboratory result represents what was happening at the time the sample was collected and may not tell the entire story.
For many women of typical menopausal age with characteristic symptoms and menstrual changes, the clinical history can provide much of the information needed to recognize the menopause transition.
Testing may still be appropriate when the history is unclear, symptoms are unusual, another condition needs to be considered, or there is another reason to obtain laboratory information. The point is not that hormone testing is never useful. It is that testing should answer a meaningful question.
Brazos should not require every woman to chase an arbitrary “optimal” estrogen or progesterone number before discussing her symptoms.
HRT is not one standardized medication or delivery method.
The appropriate approach depends on the symptoms being addressed, health history, whether the uterus is present, individual preferences, and other factors.
Estrogen is the primary hormone used to address many menopausal symptoms. Systemic estrogen can be delivered through different formulations and routes. Depending on the product, options can include oral medication and transdermal delivery through the skin. Local vaginal estrogen is another approach and is generally used for vaginal and genitourinary symptoms rather than symptoms throughout the body.
For a woman with a uterus who uses systemic estrogen, a progestogen is generally included to protect the endometrium from the effects of estrogen. The exact medication and regimen should be individualized.
Not every woman with menopausal symptoms needs systemic hormone therapy. When the primary concerns involve vaginal dryness, discomfort, or other genitourinary symptoms, local therapy may be an option. This allows the conversation to focus on the symptoms that actually need to be addressed.
Hormones can be delivered in different ways. Depending on the specific medication, options may include tablets, patches, gels, sprays, vaginal preparations, and other formulations. Different routes are not automatically interchangeable. Health history, preferences, symptoms, dosing considerations, and the specific medication all matter.
“Bioidentical” is one of the most common terms women encounter when researching HRT. It is also one of the most misunderstood. A bioidentical hormone has a chemical structure identical to a hormone produced by the human body. That description does not automatically mean the medication is compounded. There are FDA-approved hormone medications containing hormones that are chemically identical to hormones produced by the body. Compounded hormone therapy is a separate issue. Compounded medications can be useful when a commercially available FDA-approved medication cannot meet a particular patient’s needs. However, compounded medications are not FDA-approved and do not undergo the same FDA premarket review for safety, effectiveness, and quality as approved products.
The word “bioidentical” therefore should not be used as shorthand for “safer,” “better,” or “more natural.”
A more useful conversation is about the specific hormone, formulation, dose, route, evidence, and why it is being recommended for a particular woman.
There is no responsible one-word answer to this question. HRT has potential benefits and potential risks. Those risks are not identical for every woman or every hormone product. The type of hormone therapy, route, dose, timing, duration, age, medical history, and individual risk factors can all matter. The Menopause Society emphasizes individualized benefit-risk assessment based on factors including age, health, symptom severity, preferences, and available options.
The FDA also made significant changes to menopausal hormone therapy labeling in February 2026 to clarify risk considerations for these medications. The updated labeling means older blanket statements copied from legacy HRT materials may no longer accurately represent current FDA labeling. The better question is therefore:
That is a question worth discussing during an HRT evaluation.
Hormone therapy is not appropriate for everyone. Health history matters. The Menopause Society identifies several circumstances that can affect candidacy for systemic hormone therapy, including histories involving certain cancers, unexplained uterine bleeding, liver disease, blood clots, and cardiovascular disease.
This does not mean that a website checklist can determine whether an individual woman can or cannot use HRT. The details matter.
The specific condition, current health, type of hormone therapy being considered, route, age, symptoms, and other factors may all affect the decision.
That is why the consultation should include an appropriate review of health history before therapy is recommended.
Yes.
Age and timing relative to menopause can influence the benefit-risk discussion.
The decision to begin hormone therapy in a woman experiencing symptoms around the menopause transition is different from initiating systemic hormone therapy for the first time many years after menopause.
Current menopause guidance emphasizes individualization rather than applying the same risk assumptions to every woman regardless of age or timing.
This is another reason HRT should not be marketed simply as an anti-aging therapy.
The purpose, timing, symptoms, and individual health profile matter.
The decision about hormone therapy should begin before a prescription is written.
The first conversation should focus on what you are experiencing. Are you having hot flashes? Night sweats? Menstrual changes? Vaginal symptoms? Sleep disruption? When did the changes begin, and how much are they affecting your life? Understanding the reason you are seeking help gives the rest of the evaluation a purpose.
Health history can influence whether hormone therapy is appropriate and which options may be considered. Relevant information may include previous medical conditions, medications, menstrual and reproductive history, previous surgeries, family history, previous hormone use, and other health factors.
Not every woman needs the same laboratory testing before discussing HRT. Testing should be based on what the clinician is trying to understand. If symptoms or history suggest that something other than the menopause transition may be contributing, additional evaluation may be appropriate.
If hormone therapy is a reasonable option, the discussion should include what symptoms are being addressed, the type of therapy being considered, potential benefits, potential risks, and alternatives.
When HRT is used, the hormone, formulation, route, and dosing approach should fit the individual rather than a standardized package offered to every woman.
Hormone therapy should be revisited over time. Follow-up gives you and your clinician an opportunity to discuss symptom response, side effects, health changes, and whether the current approach continues to make sense.
Two women can enter the menopause transition at similar ages and have completely different experiences. One may be primarily concerned about hot flashes.
Another may be losing sleep because of repeated night sweats. Another may have few systemic symptoms but significant vaginal dryness or discomfort. Their medical histories may also be very different.
It would make little sense to assume all three need exactly the same hormone therapy.
Personalized HRT means identifying the symptoms that actually need to be addressed, considering health history and individual risk, discussing appropriate options, and reassessing how therapy is working.
It does not mean creating a custom hormone cocktail simply because “personalized” sounds better.
The care itself should be individualized.
Hormone replacement therapy is sometimes used online as an umbrella term covering both women’s hormone therapy and testosterone replacement therapy.
On the Brazos website, we should make the distinction clearer.
This page focuses on hormone replacement therapy for women, particularly in relation to perimenopause and menopause.
Testosterone replacement therapy for men involves a different evaluation, different diagnostic considerations, different risks, fertility considerations, and a different search intent.
Men looking for testosterone-specific information should continue to the dedicated TRT resource.
HRT is one possible part of the broader hormone conversation.
The parent Hormone Optimization page explains Brazos’s overall evaluation-first approach to hormone-related concerns.
This HRT page goes deeper into the specific questions women have about menopausal hormone therapy.
The relationship is simple:
Hormone Optimization → Women’s HRT Evaluation → Individualized Hormone Therapy When Appropriate
A woman does not need to arrive knowing which hormone or medication she needs.
The first job is understanding what she is experiencing and whether HRT belongs in the conversation.
You do not need to choose a hormone or delivery method before requesting a consultation.
Brazos Vitality & Precision Wellness can discuss what you are experiencing and whether hormone replacement therapy may be an appropriate option.
Not every menopausal symptom requires systemic hormone therapy.
Declining estrogen can affect the tissues of the vagina, vulva, urethra, and bladder. This collection of changes is commonly called the genitourinary syndrome of menopause, or GSM.
Symptoms can include vaginal dryness, irritation, discomfort during sexual activity, and some urinary symptoms.
For women whose symptoms are primarily vaginal or genitourinary, local therapy may be considered.
The Menopause Society identifies low-dose vaginal estrogen as an effective option for GSM after menopause.
The important point is that the therapy should fit the symptom.
A woman seeking help for vaginal dryness may have a different treatment discussion than a woman whose primary concern is frequent hot flashes and night sweats.
These are some of the most common reasons women encounter hormone marketing online. They also require careful wording. Weight changes, fatigue, and difficulty concentrating can occur during midlife, but they can have many potential causes. HRT should not be presented as a weight-loss therapy or as a guaranteed solution for fatigue or cognitive concerns. If these symptoms occur alongside the menopause transition, they are still worth discussing. The purpose of the evaluation is to understand the broader picture rather than assume that estrogen or progesterone will solve every concern. If another issue appears to be contributing, that deserves attention too.
There is not one universal timeline. How long hormone therapy remains appropriate depends on why it is being used, how symptoms change, how the woman responds, her health history, the type of therapy, and how the balance of benefits and risks evolves over time. This is why ongoing reassessment matters. The decision should not automatically be "HRT forever" or "everyone must stop at a particular birthday." Instead, continued therapy should be reviewed individually.
No. Symptoms can begin during perimenopause, before menopause has occurred. A woman may still be having menstrual periods while experiencing hot flashes, night sweats, cycle changes, sleep disruption, or other symptoms associated with the menopause transition. You do not need to wait until symptoms become severe or until menstruation has stopped for 12 months before discussing what you are experiencing. The appropriate options may differ depending on where you are in the transition, which is another reason individualized evaluation matters.
Brazos Vitality & Precision Wellness provides personalized hormone evaluation from its location at 2004 FM 2004, Suite B, Richwood, TX 77531. For women experiencing changes associated with perimenopause or menopause, the goal is not to start with a predetermined hormone package. It is to understand what has changed. Which symptoms are affecting you? Where are you in the menopause transition? What does your health history tell us? Are there factors that influence whether hormone therapy is appropriate? Which symptoms are we actually trying to address? If HRT is a reasonable option, what type of therapy makes sense? Those questions create a better starting point than assuming every woman needs the same hormone regimen.
Hormone replacement therapy, also called menopausal hormone therapy, involves using hormone medication to address certain symptoms or health effects associated with declining hormone levels during the menopause transition. Estrogen is the primary hormone used, and a progestogen is generally also needed for women with a uterus who use systemic estrogen.
HRT is the broad term for hormone replacement therapy. BHRT usually means bioidentical hormone replacement therapy. "Bioidentical" describes hormones chemically identical to hormones produced by the human body, but it does not automatically mean a product is compounded or safer than other hormone medications.
Hormone-related symptoms can begin during perimenopause before menstrual periods stop completely. Whether hormone therapy or another approach is appropriate depends on symptoms, health history, reproductive considerations, and individual circumstances.
Not always. During perimenopause, hormone levels can fluctuate, and a single measurement may not provide a complete picture. Age, menstrual changes, symptoms, and health history can often provide important information. Testing may be useful when the situation is unclear or another condition needs to be considered.
Menopausal hormone therapy is the most effective therapy for bothersome vasomotor symptoms such as hot flashes and night sweats. Whether it is appropriate for a particular woman depends on her health history and individual circumstances.
Local vaginal estrogen can be effective for vaginal and genitourinary symptoms associated with menopause. A woman whose symptoms are primarily vaginal may not necessarily need systemic hormone therapy.
The potential benefits and risks depend on the individual and the therapy being considered. Age, timing relative to menopause, medical history, type of hormone, route, dose, and other factors can influence the discussion. HRT should therefore be evaluated individually rather than described as universally safe or unsafe.
The relationship between menopausal hormone therapy and breast cancer depends on factors including the type of hormone therapy and duration of use. It should not be reduced to a blanket yes-or-no claim. Current FDA labeling and individualized risk assessment should guide the discussion. FDA approved significant menopausal hormone therapy labeling changes in February 2026, so older warning language may not reflect current labeling.
Compounded hormone therapy should not automatically be described as safer. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, and quality in the same way approved medications do. Whether compounding is appropriate depends on an individual's medical needs.
HRT should not be presented as a weight-loss therapy. Weight and body-composition changes during midlife can involve many factors. Women concerned about weight changes should have those concerns evaluated rather than assuming hormone replacement will cause weight loss.
Response varies according to the symptoms being addressed, therapy used, and individual. Brazos should add information about expected follow-up and response only after confirming the clinic's actual prescribing and monitoring protocols.
There is no single duration appropriate for every woman. Continued therapy should be periodically reassessed based on symptoms, response, health history, current risks, preferences, and the reason therapy is being used.
A hysterectomy can change the hormone-therapy discussion because whether the uterus is present affects whether endometrial protection with a progestogen is generally needed when systemic estrogen is used. The appropriate therapy still depends on the individual's medical history and circumstances.
There is not one age at which every woman should begin HRT. Symptoms, menopause timing, health history, individual risks, and the reason for considering therapy matter. Timing relative to menopause is part of the benefit-risk discussion.
If hot flashes, night sweats, vaginal changes, sleep disruption, or other changes during perimenopause or menopause are affecting how you feel, start by talking about what is actually happening.
Brazos Vitality & Precision Wellness provides personalized hormone evaluation in Richwood, Texas and can help you understand whether hormone replacement therapy may be appropriate for your individual circumstances.
Brazos Vitality & Precision Wellness
2004 FM 2004, Suite B
Richwood, TX 77531
